Brand name confusion "a risk for patients"

26 May 2002

The potential dangers of doctor's referring to the brand name alone whenprescribing drugs have been highlighted once again, when a 56-year-old German woman whom it was originally thought required a pacemaker, was in fact found to be suffering from an overdose of a blood pressure-lowering drug, reports Reuters.

The accidental overdose occurred following the woman's primary health care doctor being "apparently unaware" that a drug recently prescribed to the her contained the same active ingredient as one she was already taking, according to Matthias Schwab, of the Margarete Fischer-Bosch Institute of Pharmacology in Germany, who led a recent study into such instances of overdose.

The two drugs at the center of the confusion were Verasal and Veramex, both of which contain the calcium antagonist verapamil as their active ingredient. With reference to the mix-up Dr Schwab added that, during 2001, 15 different brands of verapamil were available across Germany and six in the USA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight